Product
Henagliflozin
Aliases
lifestyle intervention
9 clinical trials
16 indications
Indication
ObesityIndication
Unintentional Weight LossIndication
Diabetic NephropathiesIndication
Type 2 Diabetes MellitusIndication
Mild Cognitive ImpairmentIndication
Heart AttackIndication
Congestive Heart FailureIndication
Type 2 DiabetesIndication
SGLT2 inhibitorIndication
Cardiac FibrosisIndication
Magnetic Resonance ImagingIndication
Nonalcoholic Fatty Liver DiseaseIndication
Pre-DiabetesIndication
PrediabetesIndication
Glucose Metabolism DisordersIndication
Type 2 diabetesClinical trial
Efficacy of Henagliflozin for Weight Loss in Obesity Without Diabetes: a Multicenter, Randomized, Double-blind, Placebo-controlled Clinical TrialStatus: Not yet recruiting, Estimated PCD: 2026-10-01
Clinical trial
Henagliflozin Delays the Progress of Diabetic Nephropathy Via Regulates Gut-Renal AxisStatus: Not yet recruiting, Estimated PCD: 2024-12-31
Clinical trial
A Prospective, Randomized, Open Label, Parallel, 6-month Study to Explore and Evaluate the Therapeutic Effects of Henagliflozin on the Cognitive Function, Olfactory Function, and Odor-induced Brain Activation in T2DM Patients With Mild Cognitive Impairment.Status: Recruiting, Estimated PCD: 2025-06-30
Clinical trial
Clinical Study on Reducing Myocardial Infarction Siez After Primary PCI in Patients With ST Segment Elevation Myocardial Infarction by Using HenagliflozinStatus: Recruiting, Estimated PCD: 2024-10-01
Clinical trial
The Effect of Henagliflozin and Metformin on Myocardial Tissue-level Characteristics in Patients With Type 2 Diabetes and Obesity: A Prospective, Randomized, Open-label, Active Drug Controlled Clinical TrialStatus: Not yet recruiting, Estimated PCD: 2025-12-31
Clinical trial
The Study of Henagliflozin in Relieving Progression of Type 2 Diabetes With Non-alcoholic Fatty Liver DiseaseStatus: Not yet recruiting, Estimated PCD: 2025-12-31
Clinical trial
Effect of Henagliflozin on Cardiac Function in Type 2 Diabetes Patients With Chronic Heart Failure: a Multicenter, Prospective, Pragmatic Randomized Controlled TrialStatus: Recruiting, Estimated PCD: 2024-07-31
Clinical trial
Effect of Henagliflozin on the Remission of Prediabetes Population: A National Multicenter, Randomized Controlled StudyStatus: Not yet recruiting, Estimated PCD: 2026-12-01
Clinical trial
Study on the Efficacy and Safety of Henagliflozin Combined With Continuous Subcutaneous Insulin Infusion in the Treatment of Type 2 Diabetes Mellitus Based on Continuous Glucose Monitoring SystemStatus: Recruiting, Estimated PCD: 2024-07-01